These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 4388434
21. Testing for cerebrovascular reactivity. A method for estimation of the efficiency of cerebral vasodilating therapy in cerebrovascular disease. Sterman-Marinchescu C, Georgescu G, Teodorini E. Rev Roum Neurol; 1973; 10(4):325-40. PubMed ID: 4588383 [No Abstract] [Full Text] [Related]
22. [Possibility of improvement of cerebral function under the effect of prolonged combined infusions-injections oral therapy in geriatrics]. Engel K, Pramer I. Wien Med Wochenschr; 1971 Apr 03; 121(14):269-72. PubMed ID: 4397767 [No Abstract] [Full Text] [Related]
23. [Evaluation of drugs used in geriatric neuropharmacology]. Janicki PK, Rewerski W. Pol Tyg Lek; 1971 Apr 03; 40(51-52):1417-21. PubMed ID: 3913940 [No Abstract] [Full Text] [Related]
26. Clinical responses to Cinnarizin in various psychiatric syndromes. Szobor A, Klein M. Ther Hung; 1973 Apr 03; 21(1):31-4. PubMed ID: 4792889 [No Abstract] [Full Text] [Related]
27. [Clinical experiences with a vasoactive combination drug]. Hauck A, Wambsganss E. Med Welt; 1965 Jun 12; 24():1338-42. PubMed ID: 5318428 [No Abstract] [Full Text] [Related]
28. Pharmacology of dementia. Klawans HL, Genovese N. Neurol Clin; 1986 May 12; 4(2):459-67. PubMed ID: 2872586 [Abstract] [Full Text] [Related]
30. [State of the hemostasis system and pathogenetic therapy of circulatory encephalopathy]. Bekuzarova MR, Burd GS, Kolesnikova TI, Iasamanova AN, Kabanov AA. Zh Nevrol Psikhiatr Im S S Korsakova; 1997 May 12; 97(6):35-8. PubMed ID: 11517473 [No Abstract] [Full Text] [Related]
32. [Clinical results after the treatment of cases of cerebral insufficiency with centrophenoxine (Helfergin)]. Schmidt H, Broicher H. Med Welt; 1970 Aug 15; 33():1432-6. PubMed ID: 4397150 [No Abstract] [Full Text] [Related]
33. [1035 M.D. in neurologic accidents of vascular origin]. Fénelon J. J Med Bord; 1967 Dec 15; 144(12):1898-902. PubMed ID: 5622080 [No Abstract] [Full Text] [Related]
34. Vasodilating drugs and their use in cerebral symptomatology. Caplan LR. J Maine Med Assoc; 1977 Sep 15; 68(9):333-8. PubMed ID: 925513 [No Abstract] [Full Text] [Related]
36. [Effect of Acrinor on various functions of the cardiovascular system and lungs]. Jedlicka K, Krofta K, Nikodýmová L. Cas Lek Cesk; 1973 Jan 19; 112(3):80-3. PubMed ID: 4405272 [No Abstract] [Full Text] [Related]
37. [Therapeutic results with 1035 MD (apropos of 92 cases)]. Delteil P, Douche F, Fromentin M. Ann Med Psychol (Paris); 1971 Feb 19; 1(2):261-8. PubMed ID: 5577431 [No Abstract] [Full Text] [Related]
38. [The therapy of non-tubercular chronic pneumopathies studied in the reports of a geriatric hospital]. Baldoni E. G Gerontol; 1968 May 19; 16(5):428-34. PubMed ID: 4387453 [No Abstract] [Full Text] [Related]
39. [Results of 100 observations on the activity of 1035 M.D. in various neuro-psychiatric disorders due to cerebrovascular insufficiency]. Digo R, Bellot JC. Encephale; 1969 May 19; 58(3):267-82. PubMed ID: 5378185 [No Abstract] [Full Text] [Related]
40. [Clinical studies with akrinor in neuroleptically caused circulation disorders]. Eckmann F. Hippokrates; 1967 Mar 31; 38(6):239-41. PubMed ID: 4384343 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]